Scandinavian Neoadjuvant Phase III Study of Induction Chemotherapy Followed by Irradiation Alone or Surgery Plus Irradiation in NSCLC Stage IIIA/N2 (T1N2, T2N2, T3/N2).
Patients are after staging randomised to neoadj. chemotherapy followed by surgery followed
by irradiation or to chemotherapy followed by irradiation.
Endpoint is survival.
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Jens B. Sorensen, MD
Denmark: National Board of Health
Surgery in NSCLC stage IIIA/N2